Dr Reddy’s Starts Marketing Amoxicillin Tablets in US

by Kathy Jones on  September 21, 2012 at 9:52 PM Corporate News
RSS Email Print This Page Comment
Font : A-A+

Hyderabad-based pharmaceutical company Dr Reddy's Laboratories announced that it has started marketing amoxicillin tablets, capsules and oral suspension, a bioequivalent generic version of Amoxil (amoxicillin) tablets, capsules and oral suspension in the US market.
 Dr Reddy’s Starts Marketing Amoxicillin Tablets in US
Dr Reddy’s Starts Marketing Amoxicillin Tablets in US

The company said that it has received approval from the US Food and Drug Administration to market the drugs and revealed that the amoxicillin tablets will be available in 500 mg and 875 mg strengths, capsules in 250 mg and 500 mg strengths while the oral suspension will be available in 125 mg/5 ml, 200 mg/5 ml, 250 mg/5 ml, and 400 mg/5 ml strengths.



Source: Medindia

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Antibiotics 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive